ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 088,24
0,89%
Dow Jones
38 239,66
0,40%
DAX
18 161,01
1,32%
Brent Oil
88,165
0,00%
Bitcoin
63 673,57
0,41%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Adicet Bio Inc (ACET)

  7. Adicet Bio Inc (ACET) Actualités

ACET Adicet Bio Inc

1,73
-0,08 (-4,42%)
27 Avr 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Adicet Bio Inc ACET NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,08 -4,42% 1,73 00:52:14
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
1,81 1,66 1,825 1,68 1,81
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
22/4/202422:30BWAdicet Bio Highlights Preclinical Data Supporting IND..
08/4/202413:00BWAdicet Bio to Participate in 2024 Canaccord Genuity Horizons..
28/3/202422:19BWAdicet Bio Reports Inducement Grant under Nasdaq Listing..
19/3/202421:10BWAdicet Reports Fourth Quarter and Full Year 2023 Financial..
11/3/202412:00BWAdicet Bio to Participate in a Fireside Chat at the H.C...
01/3/202401:46BWAdicet Bio Reports Inducement Grant under Nasdaq Listing..
05/2/202422:01BWAdicet Bio to Participate in a Fireside Chat at the..
02/2/202417:49EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
31/1/202422:39BWAdicet Bio Reports Inducement Grant under Nasdaq Listing..
27/1/202401:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/1/202401:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202422:01BWAdicet Bio, Inc. Announces Closing of $98 Million Public..
24/1/202422:34EDGAR2Form 8-K - Current report
24/1/202422:32EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
23/1/202405:43BWAdicet Bio, Inc. Announces Pricing of Public Offering
22/1/202422:30EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
22/1/202422:28BWAdicet Bio, Inc. Announces Proposed Public Offering
19/1/202422:05EDGAR2Form SC 13G - Statement of acquisition of beneficial..
16/1/202413:01EDGAR2Form 8-K - Current report
04/1/202413:17EDGAR2Form 8-K - Current report
04/1/202413:00BWAdicet Provides Corporate Update and Highlights Strategic..
03/1/202422:01BWAdicet Bio to Host Conference Call to Provide Updates on its..
29/12/202322:50BWAdicet Bio Reports Inducement Grant under Nasdaq Listing..
10/12/202318:00BWAdicet Bio Highlights ADI-001 Expansion, Persistence and..
13/11/202322:42EDGAR2Form 8-K - Current report
08/11/202322:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202322:12EDGAR2Form 8-K - Current report
08/11/202322:10BWAdicet Reports Third Quarter 2023 Financial Results and..
07/11/202313:00BWAdicet Bio to Present at the 2023 Jefferies London..
02/11/202314:00BWAdicet Bio Announces Poster Presentation Highlighting..
31/10/202323:25BWAdicet Bio Reports Inducement Grant under Nasdaq Listing..
16/10/202322:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202318:00BWAdicet Bio Announces Poster Presentation at the Upcoming..
03/10/202322:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/9/202323:24BWAdicet Bio Reports Inducement Grants under Nasdaq Listing..
27/9/202315:00BWAdicet Bio to Present Three Scientific Posters Highlighting..
31/8/202322:35BWAdicet Bio Reports Inducement Grants under Nasdaq Listing..
17/8/202300:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/8/202300:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/8/202300:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/8/202300:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/8/202300:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/8/202300:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/8/202322:27EDGAR2Form S-8 POS - Securities to be offered to employees in..
09/8/202322:25EDGAR2Form S-8 - Securities to be offered to employees in employee..
09/8/202322:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202322:17EDGAR2Form 8-K - Current report
09/8/202322:15BWAdicet Reports Second Quarter 2023 Financial Results and..
02/8/202322:00BWAdicet Bio to Participate in a Fireside Chat at the..
31/7/202322:50BWAdicet Bio Reports Inducement Grants under Nasdaq Listing..

Dernières Valeurs Consultées

NASDAQ
ACET
Adicet Bio
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés